🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase I, open-label study to assess the safety, tolerability, pha...
Status
Completed
Location
Research Site
Start Date
2018-01-30
Trial ID
NCT03394144
Treatments Being Tested
This is a phase Ib/II, open-label multicentre study to assess the safety, t...
Status
Completed
Location
Research Site
Start Date
2018-02-07
Trial ID
NCT03421353
Treatments Being Tested
This study is designed to determine the efficacy and safety of durvalumab a...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-12-27
Trial ID
NCT03819465
The purpose of this study is to evaluate the safety, tolerability, and effi...
Status
Completed
Location
Research Site
Start Date
2016-07-13
Trial ID
NCT02549651
Treatments Being Tested
This is an open-label, multi-centre, umbrella Phase II study in participant...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-12-18
Trial ID
NCT03334617
Treatments Being Tested
This multicentre, open-label, Phase 1b/2 study is designed as a 2 part stud...
Status
Completed
Location
Research Site
Start Date
2015-08-06
Trial ID
NCT02499328
Treatments Being Tested
Study D9108C00002 (NeoCOAST) is a platform study assessing the effectivenes...
Status
Completed
Location
Research Site
Start Date
2019-03-08
Trial ID
NCT03794544
Treatments Being Tested
This is an open label, multi-drug, biomarker-directed, multi-centre, multi-...
Status
Active Not Recruiting
Location
Research Site
Start Date
2016-12-28
Trial ID
NCT02546661
Treatments Being Tested
This phase II trial studies how well danvatirsen and durvalumab work in tre...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-03-02
Trial ID
NCT02983578
Treatments Being Tested